title: Novel commercially available genomic tests for prostate cancer: a roadmap to understanding their clinical impact.
authors.affiliation: MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: John W
authors.initials: JW
authors.lastname: Davis
mesh_terms: D022126:Access to Information; D014408:Biomarkers, Tumor / Q000235:genetics; D003362:Cost-Benefit Analysis; D019175:DNA Methylation; D004273:DNA, Neoplasm; D055088:Early Detection of Cancer; D015972:Gene Expression Regulation, Neoplastic; D015894:Genome, Human; D006801:Humans; D008297:Male; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000401:mortality; D018571:Sentinel Surveillance
chemical_list: D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm